Top Medical News
2 hours ago
Enhancing plant-based diet quality over a 12-year period appears to protect against total and cardiovascular disease mortality, whereas higher consumption of an unhealthful plant-based diet increases the risk of these outcomes, according to a recent study.
Tristan Manalac, 22 hours ago
Aggressive population-level management programmes targeting hypertension and diabetes may help curtail the rise of cardiovascular diseases (CVD) and associated deaths and disabilities in Singapore, according to a recent study.
Yesterday
Age and sex do not appear to influence outcomes after percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) for left main coronary artery disease, reports a recent study.
Jairia Dela Cruz, Yesterday
Roxadustat, an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, is noninferior to parenteral epoetin alfa and performs better than placebo for correcting anaemia in kidney disease patients who are or not undergoing dialysis, according to the results of two phase III trials from China.
Tristan Manalac, Yesterday
The IsoBall (IB), a novel isometric exercise device, elicits improvements in systolic (SBP) and diastolic (DBP) blood pressure and in mean arterial pressure (MAP), according to a new study.
2 days ago
Use of the proton pump inhibitor (PPI) pantoprazole does not cut the risk of upper gastrointestinal events but may reduce the risk of bleeding from gastroduodenal lesions in patients on low-dose anticoagulants and/or antiplatelet therapy, a study has shown.
2 days ago
Inhibition of phosphodiesterase-9 (PDE9-I) is associated with improved efficacy of natriuretic peptide (NP), as well as favourable haemodynamic and renal effects in experimental heart failure (HF), a recent study has shown.
Special Reports
Prof. Rafael R. Castillo, Dr. Hyo Seung Ahn, 20 Aug 2019
Major trials have demonstrated the benefits of beta-blockers in the treatment of hypertension.1 At a recent symposium held during the Asian Pacific Society of Cardiology 2019 Congress in Manila, Philippines, experts discussed the latest guidelines on hypertension treatment, with a focus on the role of the 3rd generation beta-blocker, nebivolol. The symposium was chaired by Dr Dante D. Morales, Clinical Associate Professor at the University of the Philippines College of Medicine, and featured renowned cardiologists Prof Rafael R. Castillo and Dr Hyo Seung Ahn.
22 Jul 2019
Coenzyme Q10 (CoQ10, ubiquinone) is a fat-soluble, potent physiological antioxidant that is required for the production of cellular adenosine triphosphate (ATP). CoQ10 can be obtained through tissue synthesis and diet, and it has been widely studied in patients with cardiovascular (CV) risk factors. The effects of oral CoQ10 supplementation in different patient subgroups are presented here.
24 Apr 2019
At the recent 12th IDF-WPR Congress and 10th AASD Scientific Meeting held at Kuala Lumpur Convention Centre, the importance of glycaemic control and the practical management of type 2 diabetes mellitus (T2DM) were highlighted by two international speakers, Dr Sanjay Kalra from India and Professor Jean Claude Mbanya from Cameroon.
19 Apr 2019
At a webinar hosted by Pfizer, leading Malaysian family medicine specialists Professor Chia Yook Chin andProfessor Sherina Mohd Sidik discussed a host of issues commonly encountered in primary care, includingpreventing cardiovascular (CV) disease, pain control in osteoarthritis (OA) and depression management.
Dr. Choo Gim Hooi, Assoc Prof. Pattarapong Makarawate, Dr. Krisada Sastravaha, 17 Dec 2018
Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally and its burden is expected to increase due to the rising prevalence of risk factors such as hypertension, diabetes, and dyslipidaemia. In conjunction with the 23rd ASEAN Federation of Cardiology Congress held in Bangkok, Thailand, Menarini organized a lunch symposium and product theatre to discuss the significance of optimal medical therapy (OMT) in the management of stable CAD, with a focus on the role of ranolazine (Ranexa®).
30 Nov 2018
Despite risk factors for cardiovascular disease (CVD) being similar around the world, the burden of CVD is not uniform across nations. Furthermore, CVD-related death in low- to middle-income countries (LMICs) has increased by two-thirds in the last 30 years, and now account for a whopping 80% of global deaths due to CVD.
30 Nov 2018
Poor adherence to statin therapy is leaving many patients with dyslipidaemia at high risk of potentially life-threatening cardiovascular events. Statins are the current standard of care for reducing the risk of cardiovascular disease in these patients and for improving life expectancy, with possible economic benefits for healthcare systems too. However, many patients with dyslipidaemia are not achieving or maintaining treatment targets because they fail to stick to their prescribed statin therapy. An article co-authored by lipidologist Peter Lansberg, and published in Vascular Health and Risk Management, considers this issue and reviews approaches to overcome non-adherence.
Conference Reports
Stephen Padilla, 29 May 2019
The Duke treadmill scoring (DTS) system confers better risk stratification and provides more substantial information about the different classification of risks in patients suspected of coronary artery disease (CAD) compared with conventional treadmill reading, according to a study presented at the Asian Pacific Society of Cardiology (APSC) 2019 Congress held at the SMX Convention Center in Manila, Philippines.
Tristan Manalac, 29 May 2019
Beta blockers (BB) and renin-angiotensin inhibitors (RAI) effectively protect against anthracycline-induced cardiotoxicity among cancer patients, preserving left ventricular ejection fraction (LVEF) and cutting cardiac events, according to a new study presented at the recently concluded 2019 Congress of the Asian Pacific Society of Cardiology (APSC).
Stephen Padilla, 28 May 2019
New York Heart Association (NYHA) functional class III, multiple valve involvement and right ventricular area change predict the incidence of adverse outcomes among medically treated patients with valvular heart disease (VHD), according to a new study presented at the Asian Pacific Society of Cardiology (APSC) 2019 Congress held at the SMX Convention Center in Manila, Philippines.
Tristan Manalac, 28 May 2019
Among patients with dilated cardiomyopathy (DCM), a history of methamphetamine use does not amplify the risk of death or of nonfatal outcomes, such as myocardial infarction, stroke or heart failure, according to a study presented at the recently concluded 2019 Congress of the Asian Pacific Society of Cardiology (APSC 2019).
Jairia Dela Cruz, 28 May 2019
Among patients chronically infected with hepatitis C virus (HCV), presenting with elevated blood pressure during initiation of antiviral therapy is associated with treatment failure, according to a study presented at the Asian Pacific Society of Cardiology (APSC) Congress 2019.
Jairia Dela Cruz, 27 May 2019
Use of an intermittent pneumatic compression device as an adjunct treatment helps improve quality of life and walking endurance in patients with lower extremity arterial disease, as shown in the results of a pilot study presented at the Asian Pacific Society of Cardiology (APSC) Congress 2019.
Elvira Manzano, 26 Apr 2019
Foregoing intracardiac electrophysiologic mapping was as good as conventional cryoablation with pulmonary vein (PV) mapping in the AVATAR-HF* study, suggesting that a simplified procedure could produce the same outcomes for lower costs.
Product Highlights
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download